Management Strategies Managing these interactions requires a proactive approach: Frequent monitoring : Blood levels may need to be checked every 46 weeks when starting GLP-1 therapy to ensure the medication remains in the therapeutic range
[1] [4] Published phase 2 trial data (Jastreboff et al., NEJM , 2023) reported dose ranges from 1 mg up to 12 mg weekly, with higher doses associated with greater weight loss but also increased rates of gastrointestinal side effects
Meccanismi d'azione, dosaggio, evidenze scientifiche e associazione con i SARM PEPTIDI IMMUNOMODULANTI E ANTINFIAMMATORI ARA-290, Thymosin alfa 1, Thymulin
doi: 10.1172/JCI75276, 132 ShengL.DengM.LiX.WanH.LeiC.PrabaharK.et al
If nausea is so severe you cant work or function, or if side effects are causing significant anxiety or depression, the benefits may not outweigh the costs